Health
Revolutionizing Myasthenia Gravis Treatment: New Insights on Steroid Regimens from AAN 2025!
2025-04-10
Author: Mei
At the recent American Academy of Neurology (AAN) conference held on April 7, 2025, groundbreaking research from Peking Union Medical Hospital unveiled crucial findings about the long-term effects of steroid regimens and their withdrawal in patients with myasthenia gravis (MG). This study promises to reshape treatment standards for a condition where corticosteroids are a first-line treatment option.
Brasil (PT)
Canada (EN)
Chile (ES)
Česko (CS)
대한민국 (KO)
España (ES)
France (FR)
Hong Kong (EN)
Italia (IT)
日本 (JA)
Magyarország (HU)
Norge (NO)
Polska (PL)
Schweiz (DE)
Singapore (EN)
Sverige (SV)
Suomi (FI)
Türkiye (TR)
الإمارات العربية المتحدة (AR)